The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats

Journal of Physiology and Pharmacology

Volumn 60, Issue 3, 2009, Pages 119-125

  Adamczyk, P ^a   Mccreary, A C ^b   Przegalinski, E ^a   Mierzejewski, P ^c   Bienkowski, P ^c   Filip, M ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Solvay Pharmaceuticals Inc   (Netherlands)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Cocaine self administration; Endocannabinoid system; Fatty acid amide hydrolase inhibitors; Food self administration; Rats; Seeking behaviors

Indexed keywords

COCAINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE INHIBITOR; PHENYLMETHYLSULPHONYL FLUORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; DRUG ACTIVITY; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEEDING BEHAVIOR; LOCOMOTION; MALE; NONHUMAN; RAT; STIMULUS RESPONSE;

AMIDOHYDROLASES; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; CARBAMATES; COCAINE; COCAINE-RELATED DISORDERS; CONSUMMATORY BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENZYME INHIBITORS; EXTINCTION, PSYCHOLOGICAL; FEEDING BEHAVIOR; INJECTIONS, INTRAPERITONEAL; MALE; PHENYLMETHYLSULFONYL FLUORIDE; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 70350217362     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Koe BK. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 1976; 199: 649-661.
2. Carrera MR, Meijler MM, Janda KD. Cocaine pharmacology and current pharmacotherapies for its abuse. Bioorg Med Chem 2004; 12: 5019-5030.
3. Arnold JC. The role of endocannabinoid transmission in cocaine addiction. Pharmacol Biochem Behav 2005; 81: 396-406.
4. Elphick MR, Egertova M. The neurobiology and evolution of cannabinoid signalling. Phil Trans R Soc Lond B 2001; 356: 381-408.
5. Di Marzo V, Bifulco M, Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nature Rev Drug Discov 2004; 3: 771-784. (Pubitemid 39242829)
6. Baker D, Pryce G, Giovannoni G, Thompson AJ. The therapeutic potential of cannabis. Lancet Neurol 2003; 2: 291-298.
7. Iversen L. Cannabis and the brain. Brain 2003; 126: 1252-1270.
8. Basavarajappa BS. Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett 2007; 14: 237-246.
9. Lambert DM, Fowler CJ. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem 2005; 48: 5059-5087.
10. Pazos MR, Nunez E, Benito C, Tolon RM, Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacol Biochem Behav 2005; 81: 239-247.
11. Mechoulam R, Ben Shabat S, Hanus L, et al. Endogenous cannabinoid ligands-chemical and biological studies. J Lipid Mediat Cell Signal 1996; 14: 45-49. (Pubitemid 26343336)
12. Mechoulam R, Hanus L. A historical overview of chemical research on cannabinoids. Chem Phys Lipids 2000; 108: 1-13.
13. Foltin RW, Fischman MW, Pippen PA, Kelly TH. Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. Drug Alcohol Depend 1993; 32: 93-106. (Pubitemid 23131211)
14. Lukas SE, Sholar M, Kouri E, Fukuzako H, Mendelson JH. Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers. Pharmacol Biochem Behav 1994; 48: 715-721. (Pubitemid 24217014)
15. Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M, Fratta W. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 2001; 118: 61-65. (Pubitemid 32037114)
16. Lesscher HMB, Hoogveld E, Burbach PH, van Ree JM, Gerrits MAFM. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur Neuropsychopharmacol 2005; 15: 31-37. (Pubitemid 39574397)
17. Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W. CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 1999; 104: 141-146. (Pubitemid 29421642)
18. Higuera-Matas A, Soto-Montenegro LM, Del Olmo N, et al. Augumented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology 2008; 33: 806-813. (Pubitemid 351252702)
19. De Vries TJ, Shaham Y, Homberg JR, et al. A cannabinoid mechanism in relapse to cocaine seeking. Nature Med 2001; 7: 1151-1154. (Pubitemid 33010025)
20. Filip M, Golda A, Zaniewska M, et al. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol Rep 2006; 58: 806-819. (Pubitemid 46117732)
21. Gonzalez-Cuevas G, Aujla H, Martin-Fardon R, Lopez- Moreno JA, Navarro M, Weiss F. Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior. Neuropsychopharmacology 2007; 32: 2260-2266. (Pubitemid 47587677)
22. Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci 2006; 26: 8531-8536. (Pubitemid 44316182)
23. Filip M, Antkiewicz-Michaluk L, Zaniewska M, et al. Effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the behavioral effects of cocaine in rats. J Physiol Pharmacol 2007; 58: 625-639.
24. Filip M, Frankowska M. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur J Pharmacol 2007; 571: 166-173. (Pubitemid 47385901)
25. Frankowska M, Filip M, Przegalinski E. Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 2007; 59: 645-655. (Pubitemid 351586555)
26. Wiley JL, Dewey MA, Jefferson RG, et al. Influence of phenylmetylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sci 2000; 67: 1573-1583.
27. Compton DR, Martin BR. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J Pharmacol Exp Ther 1997; 283: 1138-1143.
28. Adamczyk P, Golda A, McCreary AC, Filip M, Przegalinski E. Activation of endocannabinoid transmission induces antidepressant-like effects in rats. J Physiol Pharmacol 2008; 59: 217-228. (Pubitemid 351955748)
29. Kathuria S, Gaetani S, Fegley D, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003; 9: 76-81. (Pubitemid 36098263)
30. Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ. Localization and mechanism of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 2001; 21: 109-116. (Pubitemid 32098732)
31. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004; 47: 345-358. (Pubitemid 39298276)
32. Diana MA, Marty A. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 2004; 142: 9-19. (Pubitemid 38698187)
33. McFarland K, Lapish CC, Kalivas PW. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2003; 23: 3531-3537. (Pubitemid 36531996)
34. Hotsenpiller G, Giorgetti M, Wolf ME. Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure. Eur J Neurosci 2001; 14: 1843-1855. (Pubitemid 35463702)
35. Gerdeman GL, Ronesi J, Lovinger DM. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nature Neurosci 2002; 5: 446-451. (Pubitemid 34454250)
36. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 2002; 99: 8384-8388. (Pubitemid 34651061)
37. Hoffman AF, Lupica CR. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 2001; 85: 72-83.
38. Manzoni OJ, Bockaert J. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur J Pharmacol 2001; 412: R3-R5. (Pubitemid 32124867)
39. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 452-457. (Pubitemid 29361798)
40. Evans RM, Scott RH, Ross RA. Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. Br J Pharmacol 2007; 152: 404-413.
41. Rubino T, Realini N, Castiglioni C, et al. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 2008; 18: 1292-1301. (Pubitemid 351769783)